Protein kinase A inhibitor attenuates levodopa-induced motor response alterations in the hemi-parkinsonian rat

Neuroscience Letters

Volumn 228, Issue 1, 1997, Pages 5-8

  Oh, Justin D ^a   Del Dotto, Paolo ^a   Chase, Thomas N ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Cyclic AMP; Dopamine; N Methyl D aspartate receptors; Parkinson's disease; Rotational behavior; Striatum

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; LEVODOPA; QUINPIROLE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DRUG EFFECT; DRUG EFFICACY; DYSKINESIA; MALE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; RAT; ROTATION;

ANIMALS; ANTIPARKINSON AGENTS; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOPAMINE AGENTS; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; LEVODOPA; MALE; MOTOR ACTIVITY; PARKINSON DISEASE; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; ROTATION; STEREOTYPED BEHAVIOR; THIONUCLEOTIDES;

EID: 0030792360     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00355-8     Document Type: Article

References (18)

1. Beninger, R.J. and Nakonechny, P.L., Dopamine D1-line receptors and molecular mechanisms of incentive learning. In R.J. Beninger, T. Palomo and D. Archer (Eds), Dopamine Disease State, Editorial CYM Press, Madrid, 1996, pp. 407-432.
2. Blanchet, P.J., Metman, L.V., Mouradian, M.M. and Chase, T.N., Acute pharmacologiec blockade of dyskinesias in Parkinson's disease, Movement Disorders, 11 (1996) 580-581.
3. Bravi, D., Mouradian, M.M., Roberts, J.W., Davies, T.L., Sohn, Y.H. and Chase, T.N., Wearing-off fluctuations in Parkinson's disease: contribution of postsynaptic mechanisms, Ann. Neurol., 36 (1993) 27-31.
4. Chase, T.N., Engber, T.M. and Mouradian, M.M., Contribution of dopaminergic and glutamatergic mechanisms to the pathogenesis of motor response complications in Parkinson's disease, Adv. Neurol., 69 (1996) 497-501.
5. Dostmann, W.R., (RP)-cAMPS inhibits the cAMP-dependent protein kinase by blocking the cAMP-induced conformational transition, FEBS Lett., 375 (1995) 231-234.
6. Engber, T.M., Papa, S.M., Boldry, R.C. and Chase, T.N., NMDA blockade reverses motor response alterations induced by levodopa, NeuroReport, 5 (1994) 2586-2588.
7. Engber, T.M., Susel, Z., Kuo, S., Gerfen, C.R. and Chase, T.N., Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats, Brain Res., 552 (1991) 113-118.
8. Kotter, R., Postsynaptic integration of glutamatergic and dopaminergic signals in the striatum, Prog. Neurobiol., 44 (1994) 163-196.
9. Le Moine, C. and Bloch, B., D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum, J. Comp. Neurol., 355 (1995) 418-426.
10. Menegoz, M., Lau, L.F., Herve, D., Huganir, R.L. and Girault, J.A., Tyrosine phosphorylation of NMDA receptor in rat striatum: effect of 6-OHdopamine lesions, NeuroReport, 7 (1995) 125-128.
11. Metman, V.L. and Eduardo, R., Locatelli, E., Bravi, D., Mouradian, M.M. and Chase, T.N., Apomorpnine responses in Parkinson's disease and the pathogenesis of motor complications, Neurology, 48 (1997) 369-372.
12. Miserendino, M.J. and Nestler, E.J., Behavioral sensitization to cocaine: modulation by the cyclic AMP system in the nucleus accumbens, Brain Res., 672 (1995) 299-306.
13. Papa, S.M., Boldry, R.C., Engber, T.M., Kask, A.M. and Chase, T.N., Reversal of levodopa-induced motor fluctuations in experimental parkinsonism by NMDA receptor blockade, Brain Res, 701 (1995) 13-18.
14. Papa, S.M. and Chase, T.N., Levodopa-induced dyskinesias improved by a glutamate antagonist in parkinsonian monkeys, Ann. Neurol., 39 (1996) 574-578.
15. Qi, M., Zhou, M., Skalheff, B.S., Brandon, E.P., Kandel, E.R., Mcknight, G.S. and Idzerda, R.L., Impaired hippocampal plasticity in mice lacking the Cb1 catalytic subunit of cAMP-dependent protein kinase, Proc. Natl. Acad. Sci. USA, 93 (1996) 1571-1576.
16. Raymond, L.A., Tingley, W.G., Blackstone, C.D., Huganir, R.L. and Raymond, L.A., Glutamate receptor modulation by protein phosphorylation, J. Physiol. Paris, 88 (1994) 181-192.
17. Starr, M.S., Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance to Parkinson's disease, Synapse, 19 (1995) 264-293.
18. Tolliver, B.K., Ho, L.B., Reid, M.S. and Berger, S.P., Evidence for involvement of ventral tegmental area cyclic AMP systems in behavioral sensitization to psychostimulants, J. Pharmacol. Exp. Ther., 278 (1996) 411-420.